Naim Alkhouri, Christine Carter‐Kent, Shadi Mayacy, Vera Hupertz, Bijan Eghtesad, Cristiano Quintini, John Fung, Kadakkal Radhakrishnan – 24 November 2009
Markus Selzner, Arash Kashfi, Mark S. Cattral, Nazia Selzner, Paul D. Greig, Les Lilly, Ian D. McGilvray, George Therapondos, Lesley E. Adcock, Anand Ghanekar, Gary A. Levy, Eberhard L. Renner, David R. Grant – 24 November 2009 – Many centers require a minimal graft to body weight ratio (GBWR) ≥ 0.8 as an arbitrary threshold to proceed with right‐lobe living donor liver transplantation (RL‐LDLT), and there is often hesitancy about transplanting lower volume living donor (LD) liver grafts into sicker patients.
Shahid M. Malik, Michael E. deVera, Paulo Fontes, Obaid Shaikh, Eizaburo Sasatomi, Jawad Ahmad – 24 November 2009 – Recurrence of the original disease following liver transplantation is not uncommon and can lead to graft failure. There are limited data on recurrent fatty liver disease following liver transplantation. The aim of this study was to determine the incidence of recurrent fatty liver disease in patients with biopsy‐proven nonalcoholic steatohepatitis, its effect on survival, and whether there are any predictive factors for recurrence.
Vishal Bhagat, Ayse L. Mindikoglu, Carmine G. Nudo, Eugene R. Schiff, Andreas Tzakis, Arie Regev – 24 November 2009 – Nonalcoholic steatohepatitis (NASH) is becoming a common cause of liver cirrhosis requiring liver transplantation (LT). Cardiovascular complications related to metabolic syndrome and NASH recurrence in the transplanted liver may affect the outcome of LT in these patients. We compared the outcomes of LT for NASH cirrhosis and alcoholic cirrhosis (ETOH) in a large transplant center.
24 November 2009
Juan F. Gallegos‐Orozco, Amir Yosephy, Brie Noble, Bashar A. Aqel, Thomas J. Byrne, Elizabeth J. Carey, David D. Douglas, David Mulligan, Adyr Moss, Giovanni de Petris, James W. Williams, Jorge Rakela, Hugo E. Vargas – 24 November 2009 – Our aim was to assess long‐term survival in patients transplanted for HCV‐related end‐stage liver disease (ESLD) and evaluate potentially modifiable predictors of survival. We performed a retrospective analysis of adult liver transplants (LT) at our institution for HCV‐related ESLD since the program's inception.
James D. Perkins – 24 November 2009
Khashayar Vakili, James J. Pomposelli, Yee Lee Cheah, Mohamed Akoad, W. David Lewis, Urmila Khettry, Fredric Gordon, Khalid Khwaja, Roger Jenkins, Elizabeth A. Pomfret – 24 November 2009 – In regions with a limited deceased donor pool, living donor adult liver transplantation (LDALT) has become an important treatment modality for patients with hepatocellular carcinoma (HCC) and cirrhosis. Studies have shown higher recurrence rates of HCC after LDALT in comparison with deceased donor liver transplantation (DDLT).
Claus U. Niemann, Ann Walia, Jeffrey Waldman, Michael Davio, John P. Roberts, Ryutaro Hirose, John Feiner – 24 November 2009 – Acute kidney injury (AKI) has significant prognostic implications for long‐term outcomes in patients undergoing liver transplantation. In several retrospective studies, perioperative variables have been associated with AKI. These variables have been mainly associated with changes in creatinine concentrations over several days or months post‐transplantation.
Gabriel Chan, Ali Taqi, Paul Marotta, Mark Levstik, Vivian McAlister, William Wall, Douglas Quan – 24 November 2009 – Acute liver failure continues to be associated with a high mortality rate, and emergency liver transplantation is often the only life‐saving treatment. The short‐term outcomes are decidedly worse in comparison with those for nonurgent cases, whereas the long‐term results have not been reported as extensively. We report our center's experience with urgent liver transplantation, long‐term survival, and major complications.